Bio-based products: AFYREN and the AFTER-BIOCHEM European consortium obtain a funding of 20 million euros.

AFYREN has successfully gathered 12 key bioeconomy players around a new European project to develop the first of its kind flagship biorefinery in France.

AFYREN meets a growing need among businesses and industries to reduce the use of petroleum-based products in their production lines. It can be achieved by producing biomolecules derived from non-food biomass, largely used in the sectors of cosmetics, flavours and fragrances, human and animal nutrition and fine chemicals. This production of renewable carbon, within a circular economy, is achieved through worldwide patented fermentation technology resulting from 10 years of research.

The AFTER-BIOCHEM (Anaerobic Fermentation & EsteRification of BIOmass for producing fine CHEMicals) consortium project aims to create innovative and more sustainable value chains from non-food biomass feedstock, by producing multiple high added-value products.

Applications will target various markets such as fragrances & flavorings, personal care, food & feed, pharmaceuticals, and industrial chemicals.

AFTER-BIOCHEM is financed with 20 million euros from the Bio-Based Industries Joint Undertaking (BBI-JU). BBI-JU is the a public-private partnership between the European Union and the Bio-based Industries Consortium (BIC), an organization that connects large and small / medium enterprises, research institutions, universities and public and private bodies at European level involved in the development of the circular bio-economy.

The project will build an all-in-one and first of its kind flagship biorefinery within the chemical platform sited at Carling-Saint-Avold (in the region GrandEst, France). AFTER-BIOCHEM’s operational coordination and plant management will rely on AFYREN NEOXY, AFYREN affiliate company, co-invested with SPI fund from Bpifrance.



3  SME, 8 large companies and 1 innovation cluster, the d’AFTER-BIOCHEM partners come from 5 European countries pôle d’innovation.


More information: Afyren Press Release


Biopôle Clermont-Limagne
Contact: Jeremy Pessiot |
Phone: +33 473 869 184